World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
42316
World Ranking
9923
National Ranking
396

Peter H. Watson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter H. Watson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 271 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter H. Watson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter H. Watson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter H. Watson is affiliated with the University of British Columbia in Canada. Their research contributes extensively to fields related to medicine and biochemistry, genetics, and molecular biology, with 51 publications in medicine and 20 publications in the latter interdisciplinary area.

The scientist's work broadly spans several specialized subfields including public health, environmental and occupational health (26 publications), physiology (13), economics and econometrics (11), cancer research (9), and molecular biology (8).

Research topics covered include ethics in clinical research (42 publications), biomedical ethics and regulation (26), health systems, economic evaluations, and quality of life (20), cancer genomics and diagnostics (16), immune cells in cancer (6), reproductive health and technologies (6), and reproductive biology and fertility (6).

Peter H. Watson's recent papers demonstrate a focus on biobanking and cancer-related research. Notable works include:

  • 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer (2021, Science Advances)
  • Improving Academic Biobank Value and Sustainability Through an Outputs Focus (2020, Value in Health)
  • Biobanking Education (2020, Biopreservation and Biobanking)
  • Biobanking for Cancer Biomarker Research: Issues and Solutions (2020, Biomarker Insights)
  • Precision medicine: Driving the evolution of biobanking quality (2020, Healthcare Management Forum)

The most frequent coauthors collaborating with Peter H. Watson include Jennifer A. Byrne (10 publications), Amanda Rush (8), Tamsin Tarling (7), Lise Matzke (6), and Sheila O'Donoghue (5).

In terms of publication venues, their work has been prominently published in Biopreservation and Biobanking (18 publications), Biomarker Insights (4), bioRxiv (Cold Spring Harbor Laboratory) (2), Science Advances (1), and Value in Health (1).

Best Publications

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • The clonal and mutational evolution spectrum of primary triple-negative breast cancers

    Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

  • Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

    Mauro Castellarin;René L. Warren;J. Douglas Freeman;Lisa Dreolini

  • Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrases

    Charles C. Wykoff;Nigel J. P. Beasley;Peter H. Watson;Kevin J. Turner

  • British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

    Rebecca C Fitzgerald;Massimiliano di Pietro;Krish Ragunath;Yeng Ang

  • Information Needs and Decisional Preferences in Women With Breast Cancer

    Lesley F. Degner;Linda J. Kristjanson;David Bowman;Jeffrey A. Sloan

  • Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

    Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.

    Heidi M. Sowter;Peter J. Ratcliffe;Peter Watson;Arnold H. Greenberg

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

    Julie S. Nielsen;Rob A. Sahota;Katy Milne;Sara E. Kost

  • Beware of connective tissue proteins: assignment and implications of collagen absorptions in infrared spectra of human tissues

    Michael Jackson;Lin-P'ing Choo;Lin-P'ing Choo;Peter H. Watson;William C. Halliday

  • Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma

    Stephen K. Chia;Charles C. Wykoff;Peter H. Watson;Cheng Han

  • Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.

    Keisuke Kurose;Kristie Gilley;Satoshi Matsumoto;Peter H. Watson

  • Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

    Katy Milne;Martin Köbel;Steven E. Kalloger;Rebecca O. Barnes

  • Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer.

    Thomas F. Hack;Lesley F. Degner;Peter Watson;Luella Sinha

  • Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer

    John R. Webb;Katy Milne;Peter Watson;Ronald J. deLeeuw

  • Altered Estrogen Receptor α and β Messenger RNA Expression during Human Breast Tumorigenesis

    Etienne Leygue;Helmut Dotzlaw;Peter H. Watson;Leigh C. Murphy

  • Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

    Nathan R West;Katy Milne;Pauline T Truong;Nicol Macpherson

  • Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology

    U. Kumar;S. I. Grigorakis;H. L. Watt;R. Sasi

Frequent Co-Authors

Leigh C. Murphy
Leigh C. Murphy University of Manitoba
Brad H. Nelson
Brad H. Nelson University of British Columbia
Robert A. Holt
Robert A. Holt BC Cancer Research Institute
adrian l harris
adrian l harris University of Oxford
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson University of Montreal
David G. Huntsman
David G. Huntsman University of British Columbia
Janusz Jankowski
Janusz Jankowski University College of Osteopathy
Peter J. Ratcliffe
Peter J. Ratcliffe The Francis Crick Institute
William E. Grizzle
William E. Grizzle University of Alabama at Birmingham
Sunil R. Lakhani
Sunil R. Lakhani University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers a variety of educational pathways beyond traditional medical school. Many students explore specialized healthcare degrees that enable them to enter leadership, clinical, or administrative roles quicker and more affordably.

For those interested in overseeing healthcare systems, online mha programs affordable are a popular choice. These programs prepare graduates for managerial roles in hospitals, clinics, and healthcare organizations, often at a lower cost than in-person programs.

Nurses looking to advance their clinical expertise can consider cheap online dnp programs. These programs allow registered nurses to earn a doctoral degree conveniently while continuing to work, opening doors to leadership and advanced practice positions.

Pharmacists also benefit from distance learning, with online pharmacy programs providing flexible and cost-effective options for earning a PharmD and meeting state licensure requirements.

Additionally, a online bachelor's in health information management can lead to rewarding careers in the rapidly growing field of medical data and health IT. These roles are vital to patient care, compliance, and healthcare administration.

Best Scientists Citing Peter H. Watson

Trending Scientists

Recently Published Articles